To Get Help Now
Click Here
 
Today's Date:

Consolidation Considered in Pradaxa Litigation

AddThis Social Bookmark Button

About 27 lawsuits have been filed in 13 district courts across the country against Boehringer Ingelheim Pharmaceuticals, Inc., over the blood thinner Pradaxa. The lawsuits allege the drug can cause serious side effects including internal bleeding events and even death. The plaintiffs in these cases allege that the drug maker failed to properly warn consumers and physicians about those risks.

One plaintiff, Leeta Witt says in May 2011, she suffered cerebral bleeding that forced her to undergo two surgeries. She said that the bleeding was the result of taking Pradaxa, which she had been taking since February 2011, for a heart rhythm disorder, the Madison Record reported.

The U.S. Judicial Panel on Multi District Litigation (JMPL) has scheduled a hearing for July 26 regarding the centralization and consolidation of the lawsuits to one court.

Currently, Pradaxa lawsuits have been filed in Tennessee, Florida, Kentucky, Oklahoma, Louisiana and Connecticut. Nearly half of the lawsuits were filed in U.S. District Court for the Southern District of Illinois.

According to Witt’s lawsuit, Boehringer confirmed at least 260 fatal bleeding events between March 2008 and October 2011, and that in December 2011 the FDA started an investigation into the bleeding events.

 

 

breakinglawsuitnews.com disclaimer: This article: Consolidation Considered in Pradaxa Litigation was posted on Monday, July 16th, 2012 at 8:50 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Comments are closed.